| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreas | 76 | 2019 | 746 | 5.420 |
Why?
|
| Pancreatic Neoplasms | 85 | 2024 | 5248 | 4.600 |
Why?
|
| Carcinoma, Pancreatic Ductal | 27 | 2024 | 1825 | 3.300 |
Why?
|
| Pancreatitis | 16 | 2019 | 293 | 2.610 |
Why?
|
| Sincalide | 28 | 2012 | 38 | 2.420 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 14 | 2024 | 1409 | 2.190 |
Why?
|
| Receptors, Cholecystokinin | 24 | 2008 | 29 | 1.930 |
Why?
|
| NF-kappa B | 18 | 2018 | 1569 | 1.710 |
Why?
|
| Calcium-Binding Proteins | 8 | 2013 | 557 | 1.550 |
Why?
|
| Acinar Cells | 7 | 2019 | 56 | 1.540 |
Why?
|
| Cholecystokinin | 24 | 2010 | 51 | 1.490 |
Why?
|
| Neoplasm Proteins | 13 | 2016 | 3363 | 1.440 |
Why?
|
| Receptors, Immunologic | 6 | 2012 | 319 | 1.350 |
Why?
|
| Trypsin | 6 | 2019 | 158 | 1.340 |
Why?
|
| Receptor for Advanced Glycation End Products | 10 | 2017 | 38 | 1.310 |
Why?
|
| Genes, ras | 7 | 2016 | 681 | 1.120 |
Why?
|
| Animals | 166 | 2024 | 62822 | 1.110 |
Why?
|
| Antigens, Surface | 4 | 2016 | 311 | 1.100 |
Why?
|
| Trypsinogen | 8 | 2019 | 9 | 1.100 |
Why?
|
| Deoxycytidine | 8 | 2020 | 1378 | 1.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 32 | 2020 | 9101 | 1.020 |
Why?
|
| Pancreas, Exocrine | 6 | 2018 | 23 | 0.990 |
Why?
|
| Pancreatitis, Chronic | 7 | 2018 | 127 | 0.990 |
Why?
|
| Receptors, Muscarinic | 10 | 1999 | 72 | 0.950 |
Why?
|
| Mice | 82 | 2024 | 36053 | 0.840 |
Why?
|
| Cell Line, Tumor | 42 | 2020 | 14881 | 0.810 |
Why?
|
| Pancreatic Stellate Cells | 11 | 2018 | 78 | 0.800 |
Why?
|
| Bombesin | 10 | 2007 | 19 | 0.800 |
Why?
|
| Gene Expression | 15 | 2019 | 3690 | 0.800 |
Why?
|
| Mice, Nude | 23 | 2019 | 4360 | 0.790 |
Why?
|
| Adenocarcinoma | 19 | 2013 | 7976 | 0.780 |
Why?
|
| RNA, Messenger | 37 | 2015 | 6489 | 0.770 |
Why?
|
| Endoplasmic Reticulum | 3 | 2008 | 334 | 0.760 |
Why?
|
| Amylases | 20 | 2008 | 67 | 0.740 |
Why?
|
| RNA, Small Interfering | 13 | 2019 | 2219 | 0.730 |
Why?
|
| Cromolyn Sodium | 2 | 2013 | 6 | 0.720 |
Why?
|
| Signal Transduction | 35 | 2019 | 12223 | 0.700 |
Why?
|
| Rats | 48 | 2012 | 6640 | 0.690 |
Why?
|
| Peptides | 6 | 2014 | 1529 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2019 | 2472 | 0.670 |
Why?
|
| Adrenomedullin | 3 | 2012 | 107 | 0.670 |
Why?
|
| S100 Proteins | 2 | 2012 | 190 | 0.660 |
Why?
|
| Inflammation | 7 | 2024 | 2535 | 0.650 |
Why?
|
| Cell Division | 24 | 2004 | 2711 | 0.640 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 152 | 0.620 |
Why?
|
| Receptors, Peptide | 2 | 2009 | 88 | 0.610 |
Why?
|
| Cathepsin E | 3 | 2013 | 6 | 0.610 |
Why?
|
| ras Proteins | 6 | 2024 | 802 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinases | 8 | 2008 | 682 | 0.590 |
Why?
|
| Gastrins | 7 | 2004 | 55 | 0.590 |
Why?
|
| Pancreatic Ducts | 8 | 2020 | 128 | 0.590 |
Why?
|
| Transgenes | 1 | 2019 | 589 | 0.580 |
Why?
|
| Xenograft Model Antitumor Assays | 12 | 2017 | 3929 | 0.560 |
Why?
|
| Carbachol | 12 | 1999 | 33 | 0.560 |
Why?
|
| Apoptosis | 14 | 2015 | 7837 | 0.550 |
Why?
|
| Cell Proliferation | 25 | 2017 | 7302 | 0.550 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 19 | 2016 | 3651 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 2624 | 0.530 |
Why?
|
| Calcium | 14 | 2004 | 1594 | 0.530 |
Why?
|
| Proteins | 7 | 2015 | 2058 | 0.520 |
Why?
|
| Diagnostic Imaging | 3 | 2014 | 1178 | 0.500 |
Why?
|
| Cell Movement | 9 | 2017 | 2504 | 0.500 |
Why?
|
| Rats, Wistar | 12 | 2006 | 601 | 0.490 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 221 | 0.490 |
Why?
|
| Metaplasia | 1 | 2016 | 387 | 0.490 |
Why?
|
| Gene Expression Regulation | 14 | 2013 | 4200 | 0.480 |
Why?
|
| Ceruletide | 10 | 2016 | 28 | 0.480 |
Why?
|
| Neoplasm Invasiveness | 14 | 2020 | 4071 | 0.480 |
Why?
|
| Mice, Transgenic | 18 | 2020 | 4371 | 0.470 |
Why?
|
| Stress, Physiological | 2 | 2008 | 494 | 0.460 |
Why?
|
| Receptors, Bombesin | 5 | 1999 | 11 | 0.450 |
Why?
|
| Transcription Factor RelA | 3 | 2012 | 186 | 0.450 |
Why?
|
| MAP Kinase Signaling System | 6 | 2020 | 889 | 0.450 |
Why?
|
| Gene Transfer Techniques | 5 | 2019 | 813 | 0.450 |
Why?
|
| RNA Interference | 12 | 2020 | 1397 | 0.440 |
Why?
|
| Cyclooxygenase 2 | 5 | 2019 | 498 | 0.440 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2011 | 2496 | 0.430 |
Why?
|
| Cell Adhesion Molecules | 4 | 2019 | 582 | 0.430 |
Why?
|
| Down-Regulation | 12 | 2020 | 2106 | 0.420 |
Why?
|
| Enzyme Activation | 14 | 2011 | 1832 | 0.420 |
Why?
|
| Humans | 110 | 2020 | 272087 | 0.420 |
Why?
|
| CA-19-9 Antigen | 3 | 2008 | 155 | 0.420 |
Why?
|
| Lactic Acid | 1 | 2014 | 312 | 0.410 |
Why?
|
| Glucocorticoids | 9 | 1992 | 622 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2014 | 487 | 0.410 |
Why?
|
| Cells, Cultured | 35 | 2013 | 5788 | 0.410 |
Why?
|
| Feedback, Physiological | 2 | 2012 | 194 | 0.400 |
Why?
|
| Neoplasms | 10 | 2019 | 15930 | 0.400 |
Why?
|
| Transforming Growth Factor beta | 6 | 2006 | 1133 | 0.400 |
Why?
|
| Precancerous Conditions | 4 | 2020 | 1065 | 0.400 |
Why?
|
| DNA-Binding Proteins | 10 | 2009 | 5067 | 0.390 |
Why?
|
| Diet, High-Fat | 3 | 2019 | 254 | 0.390 |
Why?
|
| Protein Binding | 15 | 2020 | 3528 | 0.380 |
Why?
|
| Cytokines | 7 | 2017 | 2841 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2020 | 5421 | 0.360 |
Why?
|
| Transfection | 17 | 2014 | 3166 | 0.350 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 326 | 0.350 |
Why?
|
| Insulin | 12 | 2012 | 1508 | 0.350 |
Why?
|
| Oncogenes | 3 | 2020 | 701 | 0.350 |
Why?
|
| Gene Silencing | 4 | 2018 | 834 | 0.340 |
Why?
|
| Disease Models, Animal | 16 | 2020 | 7476 | 0.340 |
Why?
|
| Tumor Cells, Cultured | 21 | 2014 | 5804 | 0.340 |
Why?
|
| Carcinoma in Situ | 2 | 2020 | 496 | 0.340 |
Why?
|
| Mutation | 16 | 2024 | 15944 | 0.330 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2008 | 1351 | 0.330 |
Why?
|
| Biomarkers, Tumor | 10 | 2020 | 10750 | 0.330 |
Why?
|
| Cation Transport Proteins | 4 | 2013 | 172 | 0.330 |
Why?
|
| Integrases | 3 | 2011 | 266 | 0.320 |
Why?
|
| Stromal Cells | 4 | 2017 | 835 | 0.320 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 14653 | 0.320 |
Why?
|
| Blood Proteins | 2 | 2017 | 301 | 0.320 |
Why?
|
| Neoplasm Metastasis | 8 | 2017 | 5330 | 0.320 |
Why?
|
| Trans-Activators | 5 | 2011 | 1660 | 0.320 |
Why?
|
| Gene Expression Profiling | 12 | 2012 | 5187 | 0.320 |
Why?
|
| Genes, Reporter | 4 | 2013 | 832 | 0.310 |
Why?
|
| Immunohistochemistry | 17 | 2016 | 7828 | 0.310 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 130 | 0.310 |
Why?
|
| Paracrine Communication | 4 | 2018 | 130 | 0.300 |
Why?
|
| Lactose | 3 | 2014 | 68 | 0.300 |
Why?
|
| CHO Cells | 12 | 2001 | 323 | 0.300 |
Why?
|
| Peptide Fragments | 3 | 2012 | 1327 | 0.290 |
Why?
|
| Up-Regulation | 8 | 2017 | 2457 | 0.290 |
Why?
|
| Epidermal Growth Factor | 7 | 1995 | 445 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2020 | 703 | 0.290 |
Why?
|
| Ornithine Decarboxylase | 3 | 1992 | 36 | 0.290 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 857 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1999 | 223 | 0.280 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2006 | 6 | 0.280 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2007 | 237 | 0.280 |
Why?
|
| Receptor, Cholecystokinin A | 7 | 2010 | 8 | 0.280 |
Why?
|
| Dexamethasone | 12 | 1996 | 1497 | 0.270 |
Why?
|
| Cricetinae | 13 | 2004 | 793 | 0.270 |
Why?
|
| Ligands | 7 | 2012 | 1057 | 0.270 |
Why?
|
| Blotting, Western | 15 | 2013 | 3646 | 0.270 |
Why?
|
| DNA | 15 | 1999 | 3089 | 0.270 |
Why?
|
| Tumor Microenvironment | 6 | 2017 | 3026 | 0.260 |
Why?
|
| Protein Folding | 1 | 2007 | 299 | 0.260 |
Why?
|
| Male | 55 | 2016 | 129088 | 0.260 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 505 | 0.260 |
Why?
|
| Quinazolines | 1 | 2010 | 953 | 0.260 |
Why?
|
| Neoplasm Transplantation | 5 | 2014 | 1566 | 0.260 |
Why?
|
| Adenoviridae | 12 | 2005 | 1514 | 0.260 |
Why?
|
| Vagus Nerve | 2 | 2008 | 70 | 0.250 |
Why?
|
| Antigens, CD | 2 | 2007 | 1436 | 0.250 |
Why?
|
| Cell Survival | 8 | 2014 | 3074 | 0.250 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 3671 | 0.250 |
Why?
|
| Chronic Disease | 6 | 2016 | 1855 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2020 | 673 | 0.250 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2013 | 611 | 0.250 |
Why?
|
| Corticosterone | 5 | 1989 | 122 | 0.250 |
Why?
|
| Visceral Afferents | 1 | 2004 | 8 | 0.250 |
Why?
|
| Disease Progression | 10 | 2018 | 6911 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 1905 | 0.240 |
Why?
|
| Transcription Factors | 7 | 2019 | 5506 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 3262 | 0.240 |
Why?
|
| Ethanol | 1 | 2006 | 270 | 0.240 |
Why?
|
| Time Factors | 19 | 2017 | 13139 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2007 | 5107 | 0.230 |
Why?
|
| Galectin 3 | 2 | 2017 | 132 | 0.230 |
Why?
|
| Carcinoma, Acinar Cell | 3 | 2009 | 87 | 0.230 |
Why?
|
| Kinetics | 15 | 2005 | 2242 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 1599 | 0.220 |
Why?
|
| Arginine | 2 | 2006 | 510 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 196 | 0.220 |
Why?
|
| Chemokines | 3 | 2018 | 296 | 0.210 |
Why?
|
| Islets of Langerhans | 4 | 2011 | 241 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2012 | 1670 | 0.210 |
Why?
|
| Thymidine | 10 | 2006 | 168 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 503 | 0.210 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2013 | 23 | 0.200 |
Why?
|
| Colonic Neoplasms | 6 | 2012 | 1443 | 0.200 |
Why?
|
| Nanoparticles | 2 | 2019 | 586 | 0.200 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2020 | 685 | 0.200 |
Why?
|
| Calcium Signaling | 4 | 2011 | 286 | 0.200 |
Why?
|
| Fluorine Radioisotopes | 2 | 2014 | 139 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2016 | 428 | 0.190 |
Why?
|
| DNA Primers | 3 | 2011 | 1513 | 0.190 |
Why?
|
| I-kappa B Kinase | 2 | 2012 | 248 | 0.190 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 116 | 0.190 |
Why?
|
| Cell Separation | 4 | 2005 | 616 | 0.180 |
Why?
|
| Dinoprostone | 2 | 2013 | 222 | 0.180 |
Why?
|
| Pancreatic Diseases | 2 | 2011 | 113 | 0.180 |
Why?
|
| Subcellular Fractions | 2 | 2017 | 212 | 0.180 |
Why?
|
| Recombinant Proteins | 10 | 2011 | 3072 | 0.180 |
Why?
|
| Flow Cytometry | 4 | 2009 | 3078 | 0.170 |
Why?
|
| Mutation Rate | 1 | 2020 | 220 | 0.170 |
Why?
|
| Smad4 Protein | 5 | 2006 | 202 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2019 | 180 | 0.170 |
Why?
|
| Retinoblastoma Protein | 2 | 1999 | 342 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2019 | 67 | 0.170 |
Why?
|
| Lectins, C-Type | 3 | 2011 | 163 | 0.170 |
Why?
|
| Glutathione Transferase | 1 | 2020 | 371 | 0.170 |
Why?
|
| Lysophospholipids | 3 | 2005 | 150 | 0.170 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 261 | 0.170 |
Why?
|
| Drug Design | 2 | 2013 | 378 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 7237 | 0.160 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 6783 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2008 | 1534 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 3417 | 0.160 |
Why?
|
| Base Sequence | 8 | 2011 | 5502 | 0.160 |
Why?
|
| Culture Media, Conditioned | 3 | 2013 | 257 | 0.160 |
Why?
|
| Receptors, Cell Surface | 5 | 2011 | 911 | 0.160 |
Why?
|
| Lipocalin-2 | 2 | 2017 | 70 | 0.160 |
Why?
|
| Transplantation, Heterologous | 5 | 2012 | 1086 | 0.160 |
Why?
|
| Receptors, Adrenomedullin | 2 | 2009 | 25 | 0.160 |
Why?
|
| Endocytosis | 2 | 2020 | 239 | 0.160 |
Why?
|
| In Vitro Techniques | 6 | 2012 | 1742 | 0.160 |
Why?
|
| Immune System | 2 | 2017 | 277 | 0.160 |
Why?
|
| Immunoprecipitation | 4 | 2009 | 593 | 0.160 |
Why?
|
| Mucoproteins | 3 | 2019 | 25 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 2 | 2019 | 263 | 0.160 |
Why?
|
| Tissue Distribution | 2 | 2017 | 946 | 0.160 |
Why?
|
| Species Specificity | 2 | 2015 | 810 | 0.150 |
Why?
|
| Threonine | 2 | 1995 | 165 | 0.150 |
Why?
|
| Radiopharmaceuticals | 3 | 2014 | 1338 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2000 | 419 | 0.150 |
Why?
|
| GTP-Binding Proteins | 5 | 2004 | 347 | 0.150 |
Why?
|
| DNA Methylation | 2 | 2007 | 2761 | 0.150 |
Why?
|
| Luciferases | 3 | 2009 | 464 | 0.150 |
Why?
|
| Gastric Mucosa | 4 | 1982 | 659 | 0.150 |
Why?
|
| Phosphorylation | 9 | 2010 | 4984 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 157 | 0.150 |
Why?
|
| Azacitidine | 1 | 2004 | 1219 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2016 | 352 | 0.150 |
Why?
|
| Antigens, Neoplasm | 4 | 2011 | 1590 | 0.150 |
Why?
|
| Phenotype | 6 | 2017 | 6517 | 0.150 |
Why?
|
| Genes, Retinoblastoma | 1 | 1997 | 93 | 0.150 |
Why?
|
| Pancreatitis-Associated Proteins | 4 | 2014 | 34 | 0.150 |
Why?
|
| Somatomedins | 3 | 1987 | 75 | 0.150 |
Why?
|
| Biomarkers | 2 | 2008 | 5115 | 0.150 |
Why?
|
| Amino Acid Sequence | 7 | 2014 | 4635 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 2017 | 132 | 0.140 |
Why?
|
| Enzyme Inhibitors | 8 | 2010 | 1966 | 0.140 |
Why?
|
| Obesity | 3 | 2019 | 2958 | 0.140 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 554 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2004 | 1668 | 0.140 |
Why?
|
| Receptor, Insulin | 3 | 1989 | 111 | 0.140 |
Why?
|
| Immunoblotting | 4 | 2009 | 909 | 0.140 |
Why?
|
| NIH 3T3 Cells | 3 | 2010 | 259 | 0.140 |
Why?
|
| Guanidines | 3 | 2012 | 61 | 0.140 |
Why?
|
| Epithelial Cells | 6 | 2013 | 1892 | 0.140 |
Why?
|
| Proteolysis | 2 | 2020 | 380 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2019 | 2975 | 0.130 |
Why?
|
| RNAi Therapeutics | 1 | 2016 | 44 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 557 | 0.130 |
Why?
|
| Microscopy, Electron | 10 | 2005 | 735 | 0.130 |
Why?
|
| Oncogene Proteins | 3 | 2019 | 370 | 0.130 |
Why?
|
| Glycolysis | 1 | 2019 | 534 | 0.130 |
Why?
|
| Cell Line | 13 | 2004 | 5433 | 0.130 |
Why?
|
| Oocytes | 5 | 1992 | 422 | 0.130 |
Why?
|
| Thiocarbamates | 3 | 2001 | 18 | 0.130 |
Why?
|
| HCT116 Cells | 2 | 2014 | 354 | 0.130 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2015 | 86 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2008 | 6210 | 0.130 |
Why?
|
| Regeneration | 3 | 2016 | 287 | 0.130 |
Why?
|
| 3T3 Cells | 4 | 2019 | 387 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2007 | 2256 | 0.130 |
Why?
|
| Gabexate | 2 | 2012 | 3 | 0.130 |
Why?
|
| Salivary Ducts | 1 | 2015 | 55 | 0.130 |
Why?
|
| Phosphatidylinositols | 5 | 1997 | 69 | 0.130 |
Why?
|
| Esters | 2 | 2012 | 49 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 1720 | 0.120 |
Why?
|
| Pyrrolidines | 3 | 2001 | 114 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4963 | 0.120 |
Why?
|
| Acute Disease | 4 | 2016 | 2517 | 0.120 |
Why?
|
| Heterografts | 2 | 2014 | 745 | 0.120 |
Why?
|
| Chemokine CXCL10 | 3 | 2000 | 106 | 0.120 |
Why?
|
| Antibodies, Blocking | 1 | 2015 | 92 | 0.120 |
Why?
|
| Sphingosine | 2 | 2005 | 59 | 0.120 |
Why?
|
| Chemokines, CXC | 3 | 2000 | 129 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2002 | 2150 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 147 | 0.120 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1993 | 19 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 898 | 0.110 |
Why?
|
| Receptors, Cholinergic | 2 | 2001 | 98 | 0.110 |
Why?
|
| Prognosis | 7 | 2017 | 22555 | 0.110 |
Why?
|
| Cullin Proteins | 1 | 2013 | 39 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 408 | 0.110 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 483 | 0.110 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 2198 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2014 | 137 | 0.110 |
Why?
|
| Receptors, Neurotransmitter | 3 | 1988 | 34 | 0.110 |
Why?
|
| Trypsin Inhibitors | 3 | 1990 | 19 | 0.110 |
Why?
|
| Chemoprevention | 2 | 2014 | 251 | 0.110 |
Why?
|
| Aminolevulinic Acid | 1 | 2013 | 20 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2013 | 99 | 0.110 |
Why?
|
| Carcinogenesis | 1 | 2019 | 1037 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1993 | 243 | 0.110 |
Why?
|
| Cell Death | 2 | 2014 | 689 | 0.110 |
Why?
|
| Secretory Pathway | 2 | 2011 | 14 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2013 | 4195 | 0.110 |
Why?
|
| ErbB Receptors | 5 | 2015 | 2383 | 0.110 |
Why?
|
| Kallikreins | 2 | 1991 | 86 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 622 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2010 | 201 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 641 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2014 | 264 | 0.100 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 53 | 0.100 |
Why?
|
| Carcinoma | 4 | 2009 | 2623 | 0.100 |
Why?
|
| Drug Synergism | 4 | 2014 | 1364 | 0.100 |
Why?
|
| HMGB1 Protein | 1 | 2012 | 40 | 0.100 |
Why?
|
| Zinc | 1 | 2013 | 194 | 0.100 |
Why?
|
| Photochemotherapy | 1 | 2013 | 116 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 262 | 0.100 |
Why?
|
| Trefoil Factor-1 | 1 | 2011 | 16 | 0.100 |
Why?
|
| Polyamines | 1 | 1992 | 80 | 0.100 |
Why?
|
| Neuroglia | 2 | 2004 | 250 | 0.100 |
Why?
|
| Oligonucleotide Probes | 1 | 2011 | 158 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2018 | 1004 | 0.100 |
Why?
|
| Wound Healing | 1 | 2016 | 760 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 2 | 2004 | 252 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 664 | 0.100 |
Why?
|
| Cyclic AMP | 6 | 2004 | 404 | 0.100 |
Why?
|
| Disaccharides | 1 | 2011 | 30 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 195 | 0.100 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2011 | 10 | 0.100 |
Why?
|
| Autoradiography | 1 | 2011 | 158 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2010 | 384 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2020 | 1077 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 184 | 0.100 |
Why?
|
| Mast Cells | 1 | 2013 | 231 | 0.100 |
Why?
|
| I-kappa B Proteins | 4 | 2012 | 177 | 0.100 |
Why?
|
| Prodrugs | 1 | 2013 | 226 | 0.100 |
Why?
|
| Cytoplasm | 5 | 2020 | 719 | 0.090 |
Why?
|
| Heat-Shock Proteins | 2 | 2007 | 339 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 203 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 507 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 165 | 0.090 |
Why?
|
| Glucosides | 1 | 2011 | 63 | 0.090 |
Why?
|
| Glycosylation | 3 | 2007 | 233 | 0.090 |
Why?
|
| Receptor, Muscarinic M3 | 3 | 1999 | 21 | 0.090 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2015 | 499 | 0.090 |
Why?
|
| Sodium | 4 | 1992 | 356 | 0.090 |
Why?
|
| Culture Techniques | 4 | 2004 | 149 | 0.090 |
Why?
|
| Caveolin 1 | 1 | 2011 | 206 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2011 | 706 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 1076 | 0.090 |
Why?
|
| Genes, fos | 2 | 2005 | 58 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2011 | 316 | 0.090 |
Why?
|
| Protein Isoforms | 3 | 2004 | 860 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 1061 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2009 | 340 | 0.090 |
Why?
|
| Adrenalectomy | 2 | 1989 | 197 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2013 | 2035 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 229 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2012 | 531 | 0.090 |
Why?
|
| Cytoplasmic Granules | 2 | 1993 | 87 | 0.090 |
Why?
|
| Genes | 2 | 2004 | 613 | 0.090 |
Why?
|
| Culture Media | 3 | 2005 | 349 | 0.090 |
Why?
|
| Models, Animal | 2 | 2012 | 675 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 584 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2000 | 252 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2011 | 186 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 441 | 0.080 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 1989 | 4 | 0.080 |
Why?
|
| Furin | 1 | 2009 | 11 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 593 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2085 | 0.080 |
Why?
|
| Pancreatic Elastase | 4 | 2011 | 35 | 0.080 |
Why?
|
| Proteomics | 2 | 2008 | 1437 | 0.080 |
Why?
|
| Models, Biological | 3 | 2019 | 3223 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 2129 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 5196 | 0.080 |
Why?
|
| Lipocalins | 1 | 2008 | 55 | 0.080 |
Why?
|
| RNA, Transfer | 1 | 1988 | 88 | 0.080 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 85 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 1999 | 304 | 0.080 |
Why?
|
| Gastric Juice | 3 | 1982 | 17 | 0.080 |
Why?
|
| Serum | 1 | 2008 | 71 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 338 | 0.080 |
Why?
|
| Neuropilin-2 | 1 | 2008 | 21 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2009 | 481 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2003 | 955 | 0.070 |
Why?
|
| Pancreatic Juice | 1 | 2007 | 12 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1212 | 0.070 |
Why?
|
| Female | 18 | 2019 | 149288 | 0.070 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2007 | 24 | 0.070 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2007 | 21 | 0.070 |
Why?
|
| Plasma | 1 | 2008 | 147 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 320 | 0.070 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 24 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1085 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2013 | 2913 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 397 | 0.070 |
Why?
|
| Cell Hypoxia | 2 | 2008 | 353 | 0.070 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2007 | 39 | 0.070 |
Why?
|
| Calcimycin | 4 | 2002 | 53 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 772 | 0.070 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 63 | 0.070 |
Why?
|
| Pericytes | 1 | 2007 | 91 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2011 | 1851 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 2099 | 0.070 |
Why?
|
| Epithelium | 1 | 2009 | 805 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2008 | 191 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 144 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2016 | 3704 | 0.070 |
Why?
|
| Second Messenger Systems | 2 | 1997 | 37 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2009 | 392 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2012 | 748 | 0.070 |
Why?
|
| GPI-Linked Proteins | 2 | 2019 | 229 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1988 | 211 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2002 | 1143 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1882 | 0.070 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2010 | 561 | 0.070 |
Why?
|
| Genes, APC | 1 | 2006 | 72 | 0.070 |
Why?
|
| Imidazoles | 1 | 2012 | 1056 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2001 | 111 | 0.070 |
Why?
|
| Receptor, Cholecystokinin B | 3 | 1998 | 4 | 0.070 |
Why?
|
| Type C Phospholipases | 4 | 2005 | 64 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2009 | 541 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 4496 | 0.070 |
Why?
|
| Gastrointestinal Agents | 1 | 1987 | 118 | 0.070 |
Why?
|
| Guanosine Triphosphate | 2 | 2024 | 106 | 0.070 |
Why?
|
| eIF-2 Kinase | 1 | 2007 | 166 | 0.070 |
Why?
|
| Biological Transport | 4 | 2004 | 645 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 599 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 1439 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2355 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 268 | 0.060 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 211 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2006 | 163 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 1295 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 81 | 0.060 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 33 | 0.060 |
Why?
|
| Guinea Pigs | 4 | 2004 | 253 | 0.060 |
Why?
|
| beta-Galactosidase | 3 | 2006 | 278 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2005 | 294 | 0.060 |
Why?
|
| Neurotransmitter Agents | 2 | 2004 | 174 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2006 | 132 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2010 | 1066 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 2 | 2019 | 514 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 41 | 0.060 |
Why?
|
| Fibrosis | 3 | 2013 | 747 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2007 | 362 | 0.060 |
Why?
|
| Phorbols | 1 | 1984 | 11 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 691 | 0.060 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2005 | 89 | 0.060 |
Why?
|
| Nodose Ganglion | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 12 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 1984 | 42 | 0.060 |
Why?
|
| Androgen-Binding Protein | 1 | 2004 | 48 | 0.060 |
Why?
|
| N-Methylscopolamine | 2 | 1999 | 3 | 0.060 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2004 | 23 | 0.060 |
Why?
|
| Tritium | 3 | 1993 | 268 | 0.060 |
Why?
|
| Sarcoma | 1 | 2015 | 1842 | 0.060 |
Why?
|
| Insulinoma | 1 | 2004 | 53 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 56 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2007 | 613 | 0.060 |
Why?
|
| Postprandial Period | 1 | 2004 | 86 | 0.060 |
Why?
|
| Reference Values | 4 | 1997 | 1155 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 16612 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2008 | 906 | 0.060 |
Why?
|
| Myenteric Plexus | 1 | 2004 | 18 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2002 | 1887 | 0.060 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2004 | 25 | 0.060 |
Why?
|
| Calreticulin | 1 | 2004 | 87 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2017 | 631 | 0.060 |
Why?
|
| Estrenes | 4 | 2005 | 31 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1996 | 1458 | 0.060 |
Why?
|
| Smad3 Protein | 2 | 2004 | 125 | 0.060 |
Why?
|
| Ionophores | 2 | 2002 | 24 | 0.060 |
Why?
|
| Enteric Nervous System | 1 | 2004 | 43 | 0.060 |
Why?
|
| Egtazic Acid | 2 | 2000 | 60 | 0.060 |
Why?
|
| Taurocholic Acid | 1 | 2003 | 16 | 0.060 |
Why?
|
| Aldosterone | 3 | 1991 | 80 | 0.060 |
Why?
|
| Devazepide | 3 | 1997 | 5 | 0.060 |
Why?
|
| Fluorouracil | 2 | 2009 | 1988 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 1248 | 0.060 |
Why?
|
| Benzodiazepinones | 3 | 1997 | 12 | 0.060 |
Why?
|
| Growth Substances | 1 | 2004 | 329 | 0.060 |
Why?
|
| Xenopus laevis | 5 | 1992 | 273 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2009 | 1049 | 0.060 |
Why?
|
| Exocytosis | 3 | 2008 | 118 | 0.050 |
Why?
|
| Serotonin | 1 | 2004 | 290 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 1146 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 2 | 2010 | 254 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2003 | 66 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2010 | 594 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 259 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 329 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 1342 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2003 | 109 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 190 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1984 | 238 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 314 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1998 | 624 | 0.050 |
Why?
|
| Poly A | 3 | 1992 | 96 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2004 | 298 | 0.050 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2017 | 5841 | 0.050 |
Why?
|
| Amphibians | 1 | 1982 | 5 | 0.050 |
Why?
|
| Ionomycin | 2 | 2000 | 35 | 0.050 |
Why?
|
| Pyrrolidinones | 3 | 2005 | 62 | 0.050 |
Why?
|
| DNA Probes | 3 | 1992 | 248 | 0.050 |
Why?
|
| Leucine | 3 | 1992 | 381 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2007 | 2335 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1435 | 0.050 |
Why?
|
| CpG Islands | 1 | 2004 | 662 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2001 | 360 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 294 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6236 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 357 | 0.050 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2004 | 318 | 0.050 |
Why?
|
| Cell Membrane | 4 | 2005 | 900 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 71 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 512 | 0.050 |
Why?
|
| Cyclins | 2 | 2001 | 470 | 0.050 |
Why?
|
| Recombination, Genetic | 2 | 2020 | 668 | 0.050 |
Why?
|
| Inositol Phosphates | 2 | 2005 | 27 | 0.050 |
Why?
|
| Adenoma | 1 | 2006 | 745 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2000 | 1740 | 0.050 |
Why?
|
| Hydrolysis | 3 | 1995 | 237 | 0.050 |
Why?
|
| Genes, erbB-1 | 1 | 2001 | 104 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2004 | 600 | 0.050 |
Why?
|
| Progesterone | 3 | 1991 | 731 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 162 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 1093 | 0.050 |
Why?
|
| Smad2 Protein | 1 | 2000 | 92 | 0.040 |
Why?
|
| Maleimides | 1 | 2000 | 23 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2001 | 138 | 0.040 |
Why?
|
| Flavonoids | 1 | 2001 | 201 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2020 | 41 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2012 | 138 | 0.040 |
Why?
|
| Collagen | 2 | 2016 | 739 | 0.040 |
Why?
|
| Blotting, Northern | 3 | 2005 | 735 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 684 | 0.040 |
Why?
|
| Logistic Models | 1 | 2007 | 3469 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 347 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 80 | 0.040 |
Why?
|
| Genes, src | 1 | 1999 | 28 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2006 | 1159 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5756 | 0.040 |
Why?
|
| Enzyme Precursors | 2 | 1996 | 71 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1999 | 95 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Endosomes | 1 | 2020 | 105 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2005 | 585 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 130 | 0.040 |
Why?
|
| Liposomes | 2 | 2014 | 711 | 0.040 |
Why?
|
| Homeodomain Proteins | 3 | 2011 | 1134 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6270 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 278 | 0.040 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2018 | 10 | 0.040 |
Why?
|
| Intracellular Fluid | 2 | 2011 | 49 | 0.040 |
Why?
|
| Carcinogens | 1 | 2000 | 398 | 0.040 |
Why?
|
| Ribonucleases | 2 | 1989 | 98 | 0.040 |
Why?
|
| Lac Operon | 2 | 2011 | 135 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2018 | 93 | 0.040 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 114 | 0.040 |
Why?
|
| Lung | 1 | 2009 | 3295 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 5001 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 128 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 231 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2018 | 281 | 0.040 |
Why?
|
| Rana pipiens | 3 | 1982 | 39 | 0.040 |
Why?
|
| Cattle | 2 | 1997 | 846 | 0.040 |
Why?
|
| Chymotrypsin | 2 | 1989 | 38 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 189 | 0.040 |
Why?
|
| Clone Cells | 1 | 1999 | 589 | 0.040 |
Why?
|
| Protein Biosynthesis | 3 | 1988 | 1035 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 7792 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 1483 | 0.040 |
Why?
|
| Aged | 7 | 2016 | 73517 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 739 | 0.040 |
Why?
|
| Galectins | 1 | 2017 | 73 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 1997 | 119 | 0.040 |
Why?
|
| Macromolecular Substances | 3 | 2005 | 342 | 0.040 |
Why?
|
| Neutrophils | 1 | 2002 | 876 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 577 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 1997 | 203 | 0.040 |
Why?
|
| Cathepsin B | 1 | 1996 | 35 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 641 | 0.030 |
Why?
|
| Indoles | 2 | 2000 | 1034 | 0.030 |
Why?
|
| Receptors, Somatotropin | 1 | 1996 | 19 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 1005 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 5996 | 0.030 |
Why?
|
| Anisomycin | 1 | 1996 | 12 | 0.030 |
Why?
|
| Mice, Inbred ICR | 2 | 2010 | 246 | 0.030 |
Why?
|
| Middle Aged | 7 | 2016 | 90460 | 0.030 |
Why?
|
| Protein Kinases | 2 | 1999 | 919 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 303 | 0.030 |
Why?
|
| Binding Sites | 5 | 2005 | 2298 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1995 | 42 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 1997 | 188 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1996 | 227 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2006 | 138 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2015 | 19 | 0.030 |
Why?
|
| United States | 2 | 2018 | 16066 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 31066 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 175 | 0.030 |
Why?
|
| Antimetabolites | 2 | 2006 | 77 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 449 | 0.030 |
Why?
|
| Receptors, Neuropeptide | 1 | 1995 | 28 | 0.030 |
Why?
|
| Albumins | 2 | 2014 | 267 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 37 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 431 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 743 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2015 | 148 | 0.030 |
Why?
|
| Adult | 5 | 2016 | 81933 | 0.030 |
Why?
|
| Pertussis Toxin | 2 | 2005 | 64 | 0.030 |
Why?
|
| Laminin | 1 | 2015 | 214 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2009 | 300 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2470 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2009 | 1074 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1209 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2014 | 53 | 0.030 |
Why?
|
| Postmenopause | 1 | 2016 | 380 | 0.030 |
Why?
|
| Thapsigargin | 1 | 1993 | 43 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1996 | 337 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2014 | 159 | 0.030 |
Why?
|
| Terpenes | 1 | 1993 | 40 | 0.030 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1993 | 70 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1986 | 245 | 0.030 |
Why?
|
| Cetuximab | 1 | 2015 | 474 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 1842 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 1995 | 349 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 201 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9326 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 320 | 0.030 |
Why?
|
| Tryptases | 1 | 2013 | 48 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2013 | 48 | 0.030 |
Why?
|
| Benzylamines | 1 | 2013 | 101 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 1997 | 600 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 600 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2013 | 88 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2006 | 214 | 0.030 |
Why?
|
| Genes, jun | 1 | 1992 | 42 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 130 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2012 | 53 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2013 | 119 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 63 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2013 | 84 | 0.030 |
Why?
|
| Lipase | 1 | 1993 | 124 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1993 | 3512 | 0.030 |
Why?
|
| Cdc20 Proteins | 1 | 2012 | 26 | 0.030 |
Why?
|
| Chymotrypsinogen | 1 | 1992 | 2 | 0.030 |
Why?
|
| Lysophospholipase | 1 | 1992 | 4 | 0.030 |
Why?
|
| Organ Size | 2 | 2010 | 727 | 0.030 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1992 | 19 | 0.030 |
Why?
|
| Chromaffin Granules | 1 | 1992 | 1 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 224 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 191 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 758 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2014 | 372 | 0.030 |
Why?
|
| Eflornithine | 1 | 1992 | 61 | 0.030 |
Why?
|
| Substance P | 2 | 1995 | 75 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1982 | 135 | 0.020 |
Why?
|
| Light | 1 | 2013 | 280 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2011 | 21 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1997 | 1972 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 344 | 0.020 |
Why?
|
| Halogenation | 1 | 2011 | 14 | 0.020 |
Why?
|
| Receptors, Histamine H2 | 1 | 1991 | 14 | 0.020 |
Why?
|
| Adiposity | 1 | 2013 | 238 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2011 | 114 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 1487 | 0.020 |
Why?
|
| Receptor, PAR-2 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 2439 | 0.020 |
Why?
|
| Receptors, Histamine H1 | 1 | 1991 | 7 | 0.020 |
Why?
|
| Diphtheria Toxin | 1 | 2011 | 83 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 16244 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2012 | 239 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 4797 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 281 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 460 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2011 | 134 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 398 | 0.020 |
Why?
|
| Genes, myc | 1 | 1992 | 375 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2018 | 802 | 0.020 |
Why?
|
| Somatostatin | 2 | 1988 | 119 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 1991 | 224 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 518 | 0.020 |
Why?
|
| Pancreatic Hormones | 1 | 1990 | 6 | 0.020 |
Why?
|
| Body Composition | 1 | 2013 | 609 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 665 | 0.020 |
Why?
|
| Macrophages | 1 | 2016 | 1378 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 98 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2010 | 68 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 18051 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 760 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 210 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 591 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 131 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1470 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 242 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 468 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 207 | 0.020 |
Why?
|
| Dishevelled Proteins | 1 | 2009 | 55 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 910 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 3856 | 0.020 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2009 | 167 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1988 | 17 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 1286 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 473 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2010 | 351 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2009 | 1230 | 0.020 |
Why?
|
| Food | 1 | 1989 | 156 | 0.020 |
Why?
|
| Microvilli | 1 | 1988 | 120 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 1105 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 790 | 0.020 |
Why?
|
| Puromycin | 1 | 1987 | 18 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 632 | 0.020 |
Why?
|
| Semaphorins | 1 | 2008 | 37 | 0.020 |
Why?
|
| Permeability | 1 | 1988 | 162 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 566 | 0.020 |
Why?
|
| Half-Life | 1 | 1988 | 269 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 210 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 12012 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 983 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 122 | 0.020 |
Why?
|
| Histamine | 2 | 1991 | 60 | 0.020 |
Why?
|
| Bethanechol | 1 | 1986 | 2 | 0.020 |
Why?
|
| Bethanechol Compounds | 1 | 1986 | 3 | 0.020 |
Why?
|
| Methacholine Compounds | 1 | 1986 | 3 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 1986 | 12 | 0.020 |
Why?
|
| Methacholine Chloride | 1 | 1986 | 29 | 0.020 |
Why?
|
| Scopolamine Derivatives | 1 | 1986 | 17 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1987 | 115 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 63 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1986 | 33 | 0.020 |
Why?
|
| Kidney | 1 | 1995 | 2266 | 0.020 |
Why?
|
| Tyrosine | 2 | 1999 | 510 | 0.020 |
Why?
|
| Secretory Rate | 1 | 1986 | 16 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2011 | 1004 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2006 | 165 | 0.020 |
Why?
|
| Cadherins | 1 | 2009 | 676 | 0.020 |
Why?
|
| Purines | 1 | 2007 | 275 | 0.020 |
Why?
|
| Liver | 2 | 2013 | 3123 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1041 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 223 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 250 | 0.020 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2006 | 153 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2005 | 32 | 0.020 |
Why?
|
| Dibutyryl Cyclic GMP | 1 | 1984 | 3 | 0.020 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2004 | 7 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2005 | 51 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2004 | 18 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2018 | 3546 | 0.020 |
Why?
|
| Microdissection | 1 | 2004 | 86 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2005 | 72 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2004 | 47 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 45 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2006 | 355 | 0.020 |
Why?
|
| Bortezomib | 1 | 2006 | 542 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 1984 | 73 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 286 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 423 | 0.010 |
Why?
|
| Integrins | 1 | 2006 | 278 | 0.010 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2004 | 3 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1984 | 196 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 341 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 1033 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 37 | 0.010 |
Why?
|
| Phosphates | 1 | 2005 | 194 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 626 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 38 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 570 | 0.010 |
Why?
|
| Sphingolipids | 1 | 2004 | 39 | 0.010 |
Why?
|
| Appetite Depressants | 1 | 1983 | 22 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 482 | 0.010 |
Why?
|
| Pyrazines | 1 | 2006 | 513 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 271 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 593 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2004 | 317 | 0.010 |
Why?
|
| Temperature | 1 | 1984 | 540 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1996 | 25 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 267 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 282 | 0.010 |
Why?
|
| Algorithms | 2 | 2004 | 3925 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 428 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2004 | 214 | 0.010 |
Why?
|
| Ouabain | 1 | 1982 | 41 | 0.010 |
Why?
|
| Microinjections | 2 | 1992 | 107 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 252 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 692 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2268 | 0.010 |
Why?
|
| Rana catesbeiana | 1 | 1982 | 3 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1982 | 5 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 1489 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 953 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 341 | 0.010 |
Why?
|
| Estradiol | 1 | 1986 | 881 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1981 | 14 | 0.010 |
Why?
|
| Bucladesine | 1 | 1981 | 32 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 4400 | 0.010 |
Why?
|
| Cisplatin | 1 | 2009 | 2497 | 0.010 |
Why?
|
| Chlorides | 1 | 1982 | 140 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 6885 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 725 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 1132 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 1278 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2009 | 1739 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 721 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 10259 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 1592 | 0.010 |
Why?
|
| Mitochondria | 1 | 1988 | 1314 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 13410 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2002 | 224 | 0.010 |
Why?
|
| Potassium | 1 | 1982 | 349 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1982 | 492 | 0.010 |
Why?
|
| Rabbits | 1 | 1982 | 1077 | 0.010 |
Why?
|
| Dogs | 2 | 1993 | 1169 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1981 | 453 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2001 | 192 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 1756 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1999 | 44 | 0.010 |
Why?
|
| Butadienes | 1 | 1999 | 36 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 642 | 0.010 |
Why?
|
| Lymphoma | 1 | 1988 | 1514 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 1312 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1999 | 143 | 0.010 |
Why?
|
| Mifepristone | 2 | 1991 | 196 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2001 | 533 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 674 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 4267 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 751 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 7958 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 3543 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1988 | 727 | 0.010 |
Why?
|
| Receptors, Somatostatin | 2 | 1988 | 94 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 5213 | 0.010 |
Why?
|
| Software | 1 | 2005 | 1387 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2002 | 1146 | 0.010 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 1996 | 15 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 819 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1996 | 175 | 0.010 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1995 | 6 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4811 | 0.010 |
Why?
|
| Bradykinin | 1 | 1995 | 89 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1997 | 451 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 1310 | 0.010 |
Why?
|
| Nitriles | 1 | 1999 | 945 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 1995 | 168 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1995 | 167 | 0.010 |
Why?
|
| Glioma | 1 | 2005 | 1988 | 0.010 |
Why?
|
| Horses | 1 | 1993 | 100 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 336 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1992 | 27 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 33909 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1992 | 38 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1993 | 293 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1992 | 582 | 0.010 |
Why?
|
| Diphenhydramine | 1 | 1991 | 20 | 0.010 |
Why?
|
| Cimetidine | 1 | 1991 | 29 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1992 | 285 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1991 | 45 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 422 | 0.010 |
Why?
|
| Hormones | 1 | 1991 | 293 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 55 | 0.010 |
Why?
|
| Swine | 1 | 1993 | 1610 | 0.000 |
Why?
|
| Exocrine Glands | 1 | 1988 | 16 | 0.000 |
Why?
|
| Pregnancy | 1 | 1982 | 8105 | 0.000 |
Why?
|
| Hybridomas | 1 | 1988 | 71 | 0.000 |
Why?
|
| Adenylyl Cyclases | 1 | 1988 | 103 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1988 | 206 | 0.000 |
Why?
|
| Hemin | 1 | 1987 | 30 | 0.000 |
Why?
|
| Feedback | 1 | 1989 | 228 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 170 | 0.000 |
Why?
|
| Immunization | 1 | 1988 | 402 | 0.000 |
Why?
|
| RNA | 1 | 1991 | 1072 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1988 | 527 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 5603 | 0.000 |
Why?
|